This website is intended for healthcare professionals only

Trending Topic

16 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Hypertension is the leading modifiable risk factor for global cardiovascular disease, responsible for an estimated 10.8 million deaths and more than 200 million disability-adjusted life years annually.1 Despite the availability of effective pharmacological and lifestyle interventions, prevalence continues to rise, particularly in low- and middle-income countries (LMICs), where over three-quarters of all cases now occur.2 The condition’s […]

68/Fusion pacing optimization with MultiPoint pacing in cardiac resynchronization therapy improves dyssynchrony of myocardial activation, an electrocardiographic imaging assessment

PH Waddingham (Presenting Author) - St Bartholomew’s Hospital, Barts Health NHS Trust, London; M Orini - St Bartholomew’s Hospital, Barts Health NHS Trust, London; J Mangual - Abbott, Sylmar; A Muthumala - St Bartholomew’s Hospital, Barts Health NHS Trust, London; S Sporton - St Bartholomew’s Hospital, Barts Health NHS Trust, London; PD Lambiase - St Bartholomew’s Hospital, Barts Health NHS Trust, London; AWC Chow - St Bartholomew’s Hospital, Barts Health NHS Trust, London
< 1 min
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Sep 27th 2010 European Journal of Arrhythmia & Electrophysiology. 2020;6(Suppl. 1):abstr68
Select a Section…
1

Article

Background: Cardiac resynchronization therapy (CRT) with MultiPoint Pacing (MPP) can improve electrical resynchronization of the left ventricle (LV) compared to conventional CRT. The SyncAV™ algorithm dynamically combines intrinsic atrioventricular (AV) conduction with pacing, improving electrical synchrony. The study objectives included assessment of the change in electrical synchrony with SyncAV and MPP, using non-invasive mapping with electrocardiographic imaging (ECGi).

Methods: Patients with LBBB (QRSd ≥150 ms), in sinus rhythm, scheduled for CRT device (MPP enabled CRT P/D, quadripolar LV lead) implantation underwent ECGi acutely. Mapping was done during intrinsic rhythm, nominal AV delay (140/110ms paced/sensed) and optimized SyncAV (individualized SyncAV offset minimizing QRSd) during: biventricular (BiV) and MultiPoint pacing (MPP). BiV activation time (AT) duration and AT dispersion on the LV (LVED=coefficient of variation of AT) were calculated.

Results: ECGi mapping was completed in 10 patients (80% male, mean age 66.4±16 years, 60% ischaemic, LVEF 30±6%, intrinsic QRSd 167±15ms) following SyncAV optimization. Compared to intrinsic conduction (AT: 136.1±15.8ms, LVED: 22.4±3.6%), AT duration was reduced using BiV SyncAV (104.2±20.4ms, p=0.027), MPP nominal (105.1±17.1ms, p=0.023) and MPP SyncAV (96.7±20.2ms, p=0.001); LVED was reduced only by MPP SyncAV (12.1±4.4ms, p=0.008). With respect to BiV nominal (119.0±31.2ms) MPP SyncAV reduced both AT duration (p=0.049) and LVED (12.1±4.4ms, p=0.049).

Conclusions: The duration and dispersion of LV activation may be reduced incrementally by SyncAV and MPP, whereas the combination of MPP and SyncAV achieved significant improvements in the dyssynchrony of activation.

2

Further Resources

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup